Walleye Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.98M Buy
93,500
+74,200
+384% +$6.72M 0.01% 1445
2026
Q2
$1.77M Sell
19,300
-32,300
-63% -$2.83M 0.01% 1620
2026
Q1
$4.4M Buy
51,600
+10,000
+24% +$891K 0.02% 885
2025
Q4
$3.29M Buy
41,600
+8,700
+26% +$682K 0.01% 1465
2025
Q3
$2.63M Sell
32,900
-24,400
-43% -$2.08M 0.01% 1374
2025
Q2
$5.21M Sell
57,300
-100
-0.2% -$9.13K 0.02% 845
2025
Q1
$5.38M Buy
57,400
+10,900
+23% +$976K 0.02% 736
2024
Q4
$4.23M Sell
46,500
-40,600
-47% -$3.87M 0.01% 1195
2024
Q3
$9.04M Sell
87,100
-65,200
-43% -$6.65M 0.02% 751
2024
Q2
$14.8M Sell
152,300
-22,500
-13% -$2.08M 0.03% 523
2024
Q1
$15.7M Buy
174,800
+44,500
+34% +$3.77M 0.03% 554
2023
Q4
$10.4M Buy
130,300
+46,600
+56% +$3.5M 0.02% 650
2023
Q3
$5.95M Buy
83,700
+29,700
+55% +$2.22M 0.02% 907
2023
Q2
$4.16M Buy
54,000
+43,700
+424% +$3.38M 0.02% 851
2023
Q1
$774K Buy
+10,300
New +$766K 0.01% 1349

Other funds holding CL

Walleye Capital's CL Position: Q3 2026 in Review

Walleye Capital increased its Colgate-Palmolive (CL) stake by 20,048% in Q3 2026, buying an estimated $26.6M and bringing the position to 295,779 shares worth $25.2M. The position accounts for 0.02% of the portfolio, ranked #661.

Walleye Capital first reported a position in CL in Q4 2021 and has held it in 15 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Walleye Capital held 295,779 shares of Colgate-Palmolive worth $25.2M as of Q3 2026.
  • Walleye Capital bought 294,311 Colgate-Palmolive shares in Q3 2026, an estimated $26.6M.
  • Colgate-Palmolive made up 0.02% of Walleye Capital's portfolio in Q3 2026, its #661 holding.
  • Walleye Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 15 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.